{"SPADE_UN_15271": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15271", "Peptide Name": "Peptide4", "Source": "Synthetic construct", "Family": "Coronaviridae", "Gene": "Not found", "Sequence": "IDENARSYIDKFQHDAEEMWYQ", "Sequence Length": 22, "UniProt Entry": "No entry found", "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Antiviral"], "Target Organism": "[Ref.34328726]SARS-CoV-2:Inhibition of virus entry in HEK293T/ACE2 cells (via inhibition of SRBD:ACE2 interaction)(IC50=32 ± 2 nM, 95% inhibition at 0.39 µM, 100% inhibition at 25 µM).", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "No cytotoxicity information or data found in the reference(s) presented in this entry", "Binding Target": "Spike protein", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C123H174N32O41S", "Mass": 2788.95, "PI": 4.29, "Net Charge": -3, "Hydrophobicity": -1.37, "Half Life": "Mammalian:20 hourYeast:30 minE.coli:>10 hour", "Mechanism of action": "antagonizes the SARS-CoV-2 S-RBD", "Literature": [{"Title": "Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein", "Pubmed ID": "34328726", "Reference": "J Med Chem. 2022 Feb 24;65(4)2836-2847.", "Author": "Sadremomtaz A, Al-Dahmani ZM, Ruiz-Moreno AJ, Monti A, Wang C, Azad T, Bell JC, Doti N, Velasco-Velázquez MA, de Jong D, de Jonge J, Smit J, Dömling A, van Goor H, Groves MR.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=34328726"}], "Frequent Amino Acids": "DEA", "Absent Amino Acids": "CGLOPTUV", "Basic Residues": 3, "Acidic Residues": 6, "Hydrophobic Residues": 9, "Polar Residues": 11, "Positive Residues": 3, "Negative Residues": 6, "Similar Sequences": []}}}